User profiles for "author:M Jayaraman"

Mahesh Jayaraman

- Verified email at lifespan.org - Cited by 8763

Mathiyarasu Jayaraman

- Verified email at cecri.res.in - Cited by 3963

Challenging the ischemic core concept in acute ischemic stroke imaging

…, JM Ospel, B Menon, M Almekhlafi, M Jayaraman… - Stroke, 2020 - Am Heart Assoc
Endovascular treatment is a highly effective therapy for acute ischemic stroke due to large
vessel occlusion and has recently revolutionized stroke care. Oftentimes, ischemic core …

Recent advances and perspectives in sweat based wearable electrochemical sensors

…, V Rajendran, RK Mishra, M Jayaraman - TrAC Trends in Analytical …, 2020 - Elsevier
The majority of existing medical diagnosis depends on the blood analysis in centralized
sophisticated laboratories having bulky, complex, and time-consuming clinical instruments …

CT of the duodenum: an overlooked segment gets its due

MV Jayaraman, WW Mayo-Smith, JS Movson… - Radiographics, 2001 - pubs.rsna.org
Abdominal computed tomography (CT) is frequently performed to evaluate gastrointestinal
pathologic conditions, and the majority of the gastrointestinal radiology literature has …

Rational design of cationic lipids for siRNA delivery

…, L Nechev, ML Eisenhardt, M Jayaraman… - Nature …, 2010 - nature.com
We adopted a rational approach to design cationic lipids for use in formulations to deliver
small interfering RNA (siRNA). Starting with the ionizable cationic lipid 1, 2-dilinoleyloxy-3 …

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

…, K Narayanannair Jayaprakash, M Jayaraman… - Nature …, 2008 - nature.com
The safe and effective delivery of RNA interference (RNAi) therapeutics remains an
important challenge for clinical development. The diversity of current delivery materials …

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

M Jayaraman, SM Ansell, BL Mui, YK Tam… - Angewandte …, 2012 - Wiley Online Library
RNA interference (RNAi) is a ubiquitous and highly effective biological mechanism to control
gene expression. Over the last few years it has been established that synthetic …

[HTML][HTML] Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

…, KN Jayaprakash, M Jayaraman… - Molecular Therapy, 2010 - cell.com
Lipid nanoparticles (LNPs) have proven to be highly efficient carriers of short-interfering
RNAs (siRNAs) to hepatocytes in vivo; however, the precise mechanism by which this …

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

C Wolfrum, S Shi, KN Jayaprakash, M Jayaraman… - Nature …, 2007 - nature.com
Cholesterol-conjugated siRNAs can silence gene expression in vivo. Here we synthesize a
variety of lipophilic siRNAs and use them to elucidate the requirements for siRNA delivery in …

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

…, W Querbes, CS Zurenko, M Jayaraman… - Nature …, 2012 - nature.com
Nanoparticles are used for delivering therapeutics into cells,. However, size, shape, surface
chemistry and the presentation of targeting ligands on the surface of nanoparticles can affect …

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

…, M Manoharan, K Fitzgerald, M Jayaraman… - Nature …, 2019 - nature.com
The regulatory approval of Onpattro, a lipid nanoparticle-based short interfering RNA drug
for the treatment of polyneuropathies induced by hereditary transthyretin amyloidosis, paves …